ArticleJournal of experimental & clinical cancer research : CR2025

EGFR inhibition augments the therapeutic efficacy of the NAT10 inhibitor Remodelin in Colorectal cancer.

Yongbin Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.